Properties
Description
PKC-theta inhibitor 1 blocks the function of Smad proteins in the TGF-β signaling pathway. It targets IL-2 production, PKCα, PKCδ, and PKCθ.
Molecular Formula
C17H15F3N4O
Targets
IL-2 production: 0.19 μM; PKCα: 1020 μM; PKCδ: 392 μM; PKCθ: 6 nM
Applications
PKC-theta inhibitor 1 can be used to enhance the anti-tumor activity of T cells, leading to improved efficacy of cancer immunotherapy approaches.